login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ARTIVA BIOTHERAPEUTICS INC (ARTV) Stock News
USA
- NASDAQ:ARTV -
US04317A1079
-
Common Stock
4.39
USD
-0.34 (-7.19%)
Last: 10/29/2025, 8:13:37 PM
4.3886
USD
0 (-0.03%)
After Hours:
10/29/2025, 8:13:37 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ARTV Latest News, Press Relases and Analysis
All
Press Releases
10 days ago - By: Chartmill
- Mentions:
XRTX
ADAP
BETR
FPAY
...
Top movers analysis in the middle of the day on 2025-10-20: top gainers and losers in today's session.
12 days ago - By: Chartmill
- Mentions:
ACHV
LBRT
EQ
RCEL
...
Top movers in Friday's session
9 days ago - By: Benzinga
- Mentions:
OMER
ACHV
RANI
4 Biotech Stocks Lifting Off As Momentum Builds
9 days ago - By: Benzinga
- Mentions:
NBY
XRTX
REPL
RAPT
...
12 Health Care Stocks Moving In Monday's Intraday Session
13 days ago - By: Chartmill
- Mentions:
F
INTC
NVDA
BYND
...
Friday's session: most active stocks
13 days ago - By: Chartmill
- Mentions:
OMER
REE
GNPX
GWH
...
In today's session, these stocks are experiencing unusual volume.
13 days ago - By: Chartmill
- Mentions:
PLX
ACHV
LBRT
STRO
...
Top stock movements in today's session.
13 days ago - By: Stocktwits
- Mentions:
IBBQ
BIB
TSLA
Artiva Biotherapeutics Gets A Price Target Hike From Wedbush: Stock Rallies 99% But Retail Expects Further Rally
13 days ago - By: Chartmill
- Mentions:
PLX
SLI
KEP
MB
...
Which stocks are gapping on Friday?
13 days ago - By: Chartmill
- Mentions:
SLI
ACHV
RCEL
YGMZ
...
Discover the top movers in Friday's pre-market session.
13 days ago - By: Chartmill
- Mentions:
THM
MSN
SLI
PRQR
...
Curious about the stocks that are showing activity after the closing bell on Thursday?
13 days ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update
13 days ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update
2 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025
2 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025
3 months ago - By: The Motley Fool
Artiva (ARTV) Q2 Loss Widens 19.7%
3 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights
5 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
5 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
6 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
6 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
6 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
6 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
6 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
6 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
7 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
7 months ago - By: Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
Please enable JavaScript to continue using this application.